‘Trojan horse’ drug targets cancerous cells but leaves surrounding tissue unharmed

‘Metabolic warhead’ molecule bypasses malignant cells’ defences before doctors use light to activate it

<p>Cancer cells are ‘greedy’ and consume more energy than healthy ones – which scientists turned to their advantage</p>

Cancer cells are ‘greedy’ and consume more energy than healthy ones – which scientists turned to their advantage

Scientists have created a “Trojan horse” drug that kills cancer cells and bacteria without harming healthy tissue nearby, in a promising development for the creation of new treatments.

However, they say more testing is needed to confirm the technique is safe and a speedy means of treating early-stage cancer. They also hope it can help tackle drug-resistant bacteria.

Researchers at the University of Edinburgh combined the tiny cancer-killing molecule SeNBD with a chemical food compound to trick malignant cells into ingesting it. They used both zebrafish and human cells for their experiments.

Cancerous cells are “greedy” and must consume high amounts of food to survive – usually more than healthy cells, the university said. When SeNBD is coupled with a compound these cells use for food it becomes “ideal prey” for them, yet does not alert them to its toxic nature.

The compound’s inventors called it a “metabolic warhead”. After it is deployed, doctors activate its cancer-killing properties by exposing it to visible light, meaning a greater degree of precision.

This reduces the chances of SeNBD destroying healthy tissues, and may help avoid side-effects like hair loss caused by other anti-cancer agents, said the university.

Professor Marc Vendrell, the project’s lead researcher and chair of translational chemistry and biomedical imaging at the University of Edinburgh, said: “This research represents an important advance in the design of new therapies that can be simply activated by light irradiation, which is generally very safe.

“SeNBD is one of the smallest photosensitisers ever made and its use as a ‘Trojan horse’ opens many new opportunities in interventional medicine for killing harmful cells without affecting surrounding healthy tissue.”

Dr Sam Benson, a post-doctoral researcher at the university, said the drug was delivered through the “front door of the cell” rather than having to “find a way to batter through the cell's defences”.

The findings are published in the journal Nature Communications.

In Greek mythology, the Trojan horse was a huge wooden statue used by the warriors of Greece to gain access to the city of Troy. They hid inside and pretended to have fled their war with the Trojans, before leaping out from inside the contraption when it was mistaken for a gift and brought inside the city walls.

Additional reporting by Press Association

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in